Síndrome neurológico transitório por anestésicos locais: um caso clínico com bupivacaína
Barra lateral de artigos
Como Citar
Esta obra está licenciado com uma Licença Creative Commons Attribution 3.0 Unported License.
##plugins.themes.bootstrap3.displayStats.downloads##
Societal impact
Conteúdo do artigo principal
Resumo
Se apresenta a história de um paciente que depois de realizar anestesia espinal com bupivacaína hiperbárica 15 mg (0.5%), mais fentanil 25 mcg, para prostatectomia aberta, apresentou dor em períneo, lombar e em membros inferiores, 24 horas depois da aplicação do anestésico local. Se descarta compromisso mecânico e eletromiográfico com tomografia, ressonância e eletromiografia. Tendo como diagnóstico definitivo a síndrome neurológico transitório. Neste caso a bupivacaína foi o agente causal. A duração dos sintomas por ao redor de três meses é um descoberta inovador em quanto ao tempo de resolução do quadro, Independente de sua associação com infecção do lugar operatório.
Detalhes do artigo
Referências
Schneider M, Ettlin T, Kaufmann M, Schumacher P, Urwyler A, Hampl K, et al. Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine. Anesth Analg 1993; 76(5):1154–1157.
Hiller A, Karjalainen K, Balk M, Rosenberg PH. Transient neurological symptoms after spinal anaesthesia with hyperbaric 5% lidocaine or general anaesthesia. Br J Anaesth 1999; 82(4):575– 579.
Keld D, Dalgaard M, Krogh L, Rodt A. The incidence of transient neurologic symptoms (TNS) after spinal anaesthesia in patients undergoing surgery in the supine position. Hyperbaric lidocaine 5% versus hyperbaric bupivacaine 0.5%. Acta Anaesthesiol Scand 2000; 44(7):285–290.
Zaric D, Christiansen C, Pace NL, Punjasawadwong Y. Transient neurologic symptoms after spinal anesthesia with lidocaine versus other local anesthetics: A systematic review of randomized, controlled trials. Anesth Analg 2005; 100(6):1811–1816.
Zaric D, Nl P. Transient neurologic symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics (Review). The Cochrane Collaboration 2009;(2).
Ddz Z, Ccc C, Nl P, Punjasawadwong Y. Transient neurologic symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics (Review). The Cochrane Collaboration 2009;(1).
Salazar F, Bogdanovich A, Adalia R, Chabas E, Gomar C. Transient neurologic symptoms after spinal anaesthesia using isobaric 2% mepivacaine and isobaric 2% lidocaine. Acta Anaesthesiol Scand 2001; 45(2):240–245.
Philip J, Sharma SK, Gottumukkala VN, Perez BJ, Slaymaker E, Wiley J. Transient neurologic symptoms after spinal anesthesia with lidocaine in obstetric patients. Anesth Analg 2001; 92(2):405–409.
Aguilar JL, Pelaez R. Transient neurological syndrome: Does it really exist? Curr Opin Anaesthesiol 2004; 17(5):423–426.
Beardsley D, Holman S, Gantt R, Robinson R, Lindsey J, Bazaral M, et al. Transient neurologic deficit after spinal anesthesia: Local anesthetic maldistribution with pencil point needles? Anesth Analg 1995; 81(2):314–320.
Pollock JE, Liu SS, Neal JM, Stephenson C. Dilution of spinal lidocaine does not alter the incidence of transient neurologic symptoms. Anesthesiology 1999; 90(2):445–450.
Cramer BG, Stienstra R, Dahan A, Arbous MS, Veering BT, Van Kleef JW. Transient neurological symptoms with subarachnoid lidocaine: Effect of early mobilization. Eur J Anaesthesiol 2005; 22(1):35–39.
Farid I, Hernandez-Popp V, Youssef GN, Mekhail N. Bupivacaine induces transient neurological symptoms after subarachnoid block. Pain Practice 2002; 2(1):53–55.
Myer R, Klichman M, Reisner L, Powell H. Neurotoxicity of local anesthetics: Altered perineural permeability, edema, and nerve fiber injury. Anesthesiology 1986; 64(1):29–35.
Sakura S, Bollen a W, Ciriales R, Drasner K. Local anesthetic neurotoxicity does not result from blockade of voltage-gated sodium channels. Anesth Analg 1995; 81(2):338–346.
Wang BC, Hillman DE, Spielholz NI, Turndorf H. Chronic neurological deficits and NesacaineCE-an effect of the anesthetic, 2-chloroprocaine, or the antioxidant, sodium bisulfite? Anesth Analg 1984; 63(4):445–447.
Kanai Y, Katsuki H, Takasaki M. Lidocaine disrupts axonal membrane of rat sciatic nerve in vitro. Anesth Analg 2000; 91(4):944–948.